Published in Nature on September 14, 2016
The Principles of Engineering Immune Cells to Treat Cancer. Cell (2017) 0.85
Kv1.3 channels mark functionally competent CD8+ tumor infiltrating lymphocytes in head and neck cancer. Cancer Res (2016) 0.82
The Unique Molecular and Cellular Microenvironment of Ovarian Cancer. Front Oncol (2017) 0.81
Immunology: Channelling potassium to fight cancer. Nature (2016) 0.76
Identification and Characterization of a Novel Association between Dietary Potassium and Risk of Crohn's Disease and Ulcerative Colitis. Front Immunol (2016) 0.75
Immunosuppressive cell death in cancer. Nat Rev Immunol (2017) 0.75
Pro-inflammatory Ca(++)-activated K(+) channels are inhibited by hydroxychloroquine. Sci Rep (2017) 0.75
Potassium channels of T lymphocytes take center stage in the fight against cancer. J Immunother Cancer (2017) 0.75
Immunometabolic Regulation of Interleukin-17-Producing T Helper Cells: Uncoupling New Targets for Autoimmunity. Front Immunol (2017) 0.75
Nutrient and Metabolic Sensing in T Cell Responses. Front Immunol (2017) 0.75
Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies. Cancer Cell (2017) 0.75
Novel "Elements" of Immune Suppression within the Tumor Microenvironment. Cancer Immunol Res (2017) 0.75
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor. Nat Immunol (2017) 0.75
mTOR signaling in the differentiation and function of regulatory and effector T cells. Curr Opin Immunol (2017) 0.75
Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy. Cell Metab (2017) 0.75
The intragraft microenvironment as a central determinant of chronic rejection or local immunoregulation/tolerance. Curr Opin Organ Transplant (2016) 0.75
A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol (1952) 160.83
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol (2010) 75.21
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med (2015) 13.08
POTENTIAL, IMPEDANCE, AND RECTIFICATION IN MEMBRANES. J Gen Physiol (1943) 13.08
Cancer immunotherapy comes of age. Nature (2011) 12.35
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol (2011) 9.19
Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature (2002) 7.53
Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. Science (2014) 6.88
Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity (2011) 5.43
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature (2013) 4.74
K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity (2013) 3.96
The functional network of ion channels in T lymphocytes. Immunol Rev (2009) 3.21
Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol (2005) 3.21
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. J Clin Invest (2003) 3.02
Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature (2011) 2.82
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses. Cell (2015) 2.60
Quantification of PtdInsP3 molecular species in cells and tissues by mass spectrometry. Nat Methods (2011) 2.56
STATs shape the active enhancer landscape of T cell populations. Cell (2012) 2.45
ORAI1 and STIM1 deficiency in human and mice: roles of store-operated Ca2+ entry in the immune system and beyond. Immunol Rev (2009) 2.43
Cutting edge: re-evaluating the in vivo cytokine responses of CD8+ T cells during primary and secondary viral infections. J Immunol (2005) 2.22
T cell metabolism drives immunity. J Exp Med (2015) 2.06
In vivo discovery of immunotherapy targets in the tumour microenvironment. Nature (2014) 2.05
Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma. J Clin Oncol (2016) 1.89
Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins. Cell (2006) 1.88
Immunogenicity of somatic mutations in human gastrointestinal cancers. Science (2015) 1.87
Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival. Proc Natl Acad Sci U S A (2010) 1.85
The Ca(v)1.4 calcium channel is a critical regulator of T cell receptor signaling and naive T cell homeostasis. Immunity (2011) 1.73
Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance. J Exp Med (2015) 1.58
Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions. Clin Cancer Res (2014) 1.56
Tumor Lysis Syndrome in Solid Tumors: An up to Date Review of the Literature. Rare Tumors (2014) 1.48
Sphingolipid signaling in metabolic disorders. Cell Metab (2012) 1.37
Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression. Cancer Immunol Immunother (2008) 1.21
Type I cytokines synergize with oncogene inhibition to induce tumor growth arrest. Cancer Immunol Res (2014) 1.17
The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review. Future Oncol (2011) 1.09
Modulation of Kv channel expression and function by TCR and costimulatory signals during peripheral CD4(+) lymphocyte differentiation. J Exp Med (2002) 1.07
EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex. Nat Commun (2012) 1.03
Interstitial fluid: the overlooked component of the tumor microenvironment? Fibrogenesis Tissue Repair (2010) 1.02
Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease. Future Med Chem (2011) 0.98
Modulation of the enzymatic properties of protein phosphatase 2A catalytic subunit by the recombinant 65-kDa regulatory subunit PR65alpha. Eur J Biochem (1997) 0.98
Use of a blood gas analyzer and a laboratory autoanalyzer in routine practice to measure electrolytes in intensive care unit patients. BMC Anesthesiol (2012) 0.98
Kv1.3 channels can modulate cell proliferation during phenotypic switch by an ion-flux independent mechanism. Arterioscler Thromb Vasc Biol (2012) 0.95
A new method for isolation of interstitial fluid from human solid tumors applied to proteomic analysis of ovarian carcinoma tissue. PLoS One (2011) 0.92
Modulation of cytolytic T lymphocyte functions by an inhibitor of serine/threonine phosphatase, okadaic acid. Enhancement of cytolytic T lymphocyte-mediated cytotoxicity. J Immunol (1991) 0.83
Pus potassium. Inflammation (1988) 0.82
Direct inhibition of phospholipid scrambling activity in erythrocytes by potassium ions. Cell Mol Life Sci (2009) 0.82
Molecular Determinants of Kv1.3 Potassium Channels-induced Proliferation. J Biol Chem (2015) 0.79
Haematological cancer: idelalisib-targeting PI3Kδ in patients with B-cell malignancies. Nat Rev Clin Oncol (2014) 0.87
Identification of essential genes for cancer immunotherapy. Nature (2017) 0.75
BACH transcription factors in innate and adaptive immunity. Nat Rev Immunol (2017) 0.75